LH
43
-2
NTAP
67
-3
PFE
23
7
STI
14
-17
NKE
36
6
CFG
70
6
GIS
31
3
BA
54
5
PLD
56
8
WU
32
2
RSG
71
3
HON
67
2
HP
48
3
BWA
48
2
VRSN
53
-4
LMT
34
2
PRGO
39
3
RL
72
4
LNC
39
3
AMG
54
2
LH
43
-2
NTAP
67
-3
PFE
23
7
STI
14
-17
NKE
36
6
CFG
70
6
GIS
31
3
BA
54
5
PLD
56
8
WU
32
2
RSG
71
3
HON
67
2
HP
48
3
BWA
48
2
VRSN
53
-4
LMT
34
2
PRGO
39
3
RL
72
4
LNC
39
3
AMG
54
2
Financhill
Back

Arbutus Biopharma Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
24.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Arbutus Biopharma Price Quote

$3.51

Arbutus Biopharma Key Stats

Sell
37
Arbutus Biopharma (ABUS) is a Sell
Day range:
$3.45 - $3.53
52-week range:
$1.79 - $4.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
93.87
P/B ratio:
6.22%
Volume:
716.5K
Avg. volume:
919.1K
1-year change:
90.76%
Market cap:
$665.1M
Revenue:
$18.1M
EPS:
$-0.43

How Much Does Arbutus Biopharma Make?

Is Arbutus Biopharma Growing As A Company?

  • What Is Arbutus Biopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.71%
  • What Is Arbutus Biopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Arbutus Biopharma Stock Price Performance

What Is Arbutus Biopharma 52-Week High & Low?

Arbutus Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Arbutus Biopharma?

  • How Much Debt Does Arbutus Biopharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Arbutus Biopharma Have?
    Cash and short term investments quarterly total is $127.8M
  • What Is Arbutus Biopharma’s Book Value Per Share?
    Book value per share is 0.56

Is Arbutus Biopharma Cash Flow Positive?

  • What Is ABUS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$71.8M
  • What Is Arbutus Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.4M
  • What Is Arbutus Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $31.8M

Arbutus Biopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ABUS return on invested capital is -67.36%
  • What Is Arbutus Biopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -50.88%
  • What Is ABUS Return On Equity?
    ROE is a measure of profitability and is -67.36%

Arbutus Biopharma Earnings Date & Stock Price

Arbutus Biopharma Competitors

  • Who Are Arbutus Biopharma's Competitors?
    Below is a list of companies who compete with Arbutus Biopharma or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • FibroGen Inc (FGEN)
    • Amicus Therapeutics Inc (FOLD)
    • GlycoMimetics Inc (GLYC)
    • Ionis Pharmaceuticals Inc (IONS)

Arbutus Biopharma Dividend Yield

Arbutus Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.95%
Revenue: -71.25% -28.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 5.22
Upside from Last Price: 48.64%

Major Shareholders

  • How many ABUS shares are owned by institutional investors?
    165.1M ABUS shares are owned by institutional investors
  • How many ABUS shares are owned by insiders?
    6.8M ABUS shares are owned by insiders